224 related articles for article (PubMed ID: 33950564)
1. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.
Wang S; Denton KE; Hobbs KF; Weaver T; McFarlane JMB; Connelly KE; Gignac MC; Milosevich N; Hof F; Paci I; Musselman CA; Dykhuizen EC; Krusemark CJ
ACS Chem Biol; 2020 Jan; 15(1):112-131. PubMed ID: 31755685
[TBL] [Abstract][Full Text] [Related]
3. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming CBX8-PRC1 function with a positive allosteric modulator.
Suh JL; Bsteh D; Hart B; Si Y; Weaver TM; Pribitzer C; Lau R; Soni S; Ogana H; Rectenwald JM; Norris JL; Cholensky SH; Sagum C; Umana JD; Li D; Hardy B; Bedford MT; Mumenthaler SM; Lenz HJ; Kim YM; Wang GG; Pearce KH; James LI; Kireev DB; Musselman CA; Frye SV; Bell O
Cell Chem Biol; 2022 Apr; 29(4):555-571.e11. PubMed ID: 34715055
[TBL] [Abstract][Full Text] [Related]
5. PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1.
Glancy E; Wang C; Tuck E; Healy E; Amato S; Neikes HK; Mariani A; Mucha M; Vermeulen M; Pasini D; Bracken AP
Mol Cell; 2023 May; 83(9):1393-1411.e7. PubMed ID: 37030288
[TBL] [Abstract][Full Text] [Related]
6. Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes.
Lercher L; Simon N; Bergmann A; Tauchert M; Bochmann D; Bashir T; Neuefeind T; Riley D; Danna B; Krawczuk P; Pande V; Patrick A; Steele R; Wang W; Rupnow B; Tummino P; Sharma S; Finley M
SLAS Discov; 2022 Jul; 27(5):306-313. PubMed ID: 35513262
[TBL] [Abstract][Full Text] [Related]
7. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.
Vandamme J; Völkel P; Rosnoblet C; Le Faou P; Angrand PO
Mol Cell Proteomics; 2011 Apr; 10(4):M110.002642. PubMed ID: 21282530
[TBL] [Abstract][Full Text] [Related]
8. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences.
Vincenz C; Kerppola TK
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16572-7. PubMed ID: 18927235
[TBL] [Abstract][Full Text] [Related]
9. Cbx2 stably associates with mitotic chromosomes via a PRC2- or PRC1-independent mechanism and is needed for recruiting PRC1 complex to mitotic chromosomes.
Zhen CY; Duc HN; Kokotovic M; Phiel CJ; Ren X
Mol Biol Cell; 2014 Nov; 25(23):3726-39. PubMed ID: 25232004
[TBL] [Abstract][Full Text] [Related]
10. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3.
Hatano A; Matsumoto M; Higashinakagawa T; Nakayama KI
Biochem Biophys Res Commun; 2010 Jun; 397(1):93-9. PubMed ID: 20493168
[TBL] [Abstract][Full Text] [Related]
12. A human Polycomb isoform lacking the Pc box does not participate to PRC1 complexes but forms protein assemblies and represses transcription.
Völkel P; Le Faou P; Vandamme J; Pira D; Angrand PO
Epigenetics; 2012 May; 7(5):482-91. PubMed ID: 22419124
[TBL] [Abstract][Full Text] [Related]
13. Cbx2 targets PRC1 to constitutive heterochromatin in mouse zygotes in a parent-of-origin-dependent manner.
Tardat M; Albert M; Kunzmann R; Liu Z; Kaustov L; Thierry R; Duan S; Brykczynska U; Arrowsmith CH; Peters AH
Mol Cell; 2015 Apr; 58(1):157-71. PubMed ID: 25801166
[TBL] [Abstract][Full Text] [Related]
14. The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation.
Liu H; Li Z; Li L
Comput Biol Chem; 2018 Jun; 74():339-346. PubMed ID: 29723807
[TBL] [Abstract][Full Text] [Related]
15. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
16. Engagement of DNA and H3K27me3 by the CBX8 chromodomain drives chromatin association.
Connelly KE; Weaver TM; Alpsoy A; Gu BX; Musselman CA; Dykhuizen EC
Nucleic Acids Res; 2019 Mar; 47(5):2289-2305. PubMed ID: 30597065
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.
Ren C; Morohashi K; Plotnikov AN; Jakoncic J; Smith SG; Li J; Zeng L; Rodriguez Y; Stojanoff V; Walsh M; Zhou MM
Chem Biol; 2015 Feb; 22(2):161-8. PubMed ID: 25660273
[TBL] [Abstract][Full Text] [Related]
18. Phase-Separated Transcriptional Condensates Accelerate Target-Search Process Revealed by Live-Cell Single-Molecule Imaging.
Kent S; Brown K; Yang CH; Alsaihati N; Tian C; Wang H; Ren X
Cell Rep; 2020 Oct; 33(2):108248. PubMed ID: 33053359
[TBL] [Abstract][Full Text] [Related]
19. Interdependence of PRC1 and PRC2 for recruitment to Polycomb Response Elements.
Kahn TG; Dorafshan E; Schultheis D; Zare A; Stenberg P; Reim I; Pirrotta V; Schwartz YB
Nucleic Acids Res; 2016 Dec; 44(21):10132-10149. PubMed ID: 27557709
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific role of CBX2 and its disordered region in spermatogenesis.
Kim JJ; Steinson ER; Lau MS; de Rooij DG; Page DC; Kingston RE
Genes Dev; 2023 Jul; 37(13-14):640-660. PubMed ID: 37553262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
